Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of the immunogenicity and safety of the purified chick embryo cell rabies vaccine manufactured in India and Germany: A randomized, single blind, multicentre, phase IV clinical study.
Sampath G, Banzhoff A, Deshpande A, Malerczyk C, Arora AK, Vakil H, Preiss S. Sampath G, et al. Among authors: arora ak. Hum Vaccin Immunother. 2017 Jul 3;13(7):1531-1538. doi: 10.1080/21645515.2017.1307483. Epub 2017 Apr 13. Hum Vaccin Immunother. 2017. PMID: 28406752 Free PMC article. Clinical Trial.
A dose-ranging study of MF59(®)-adjuvanted and non-adjuvanted A/H1N1 pandemic influenza vaccine in young to middle-aged and older adult populations to assess safety, immunogenicity, and antibody persistence one year after vaccination.
Reisinger KS, Holmes SJ, Pedotti P, Arora AK, Lattanzi M. Reisinger KS, et al. Among authors: arora ak. Hum Vaccin Immunother. 2014;10(8):2395-407. doi: 10.4161/hv.29393. Hum Vaccin Immunother. 2014. PMID: 25424947 Free PMC article. Clinical Trial.
Comparative study on the immunogenicity and safety of a purified chick embryo cell rabies vaccine (PCECV) administered according to two different simulated post exposure intramuscular regimens (Zagreb versus Essen).
Mahendra BJ, Narayana DA, Agarkhedkar S, Ravish HS, Harish BR, Agarkhedkar S, Madhusudana SN, Belludi A, Ahmed K, Jonnalagedda R, Vakil H, Bhusal C, Arora AK. Mahendra BJ, et al. Among authors: arora ak. Hum Vaccin Immunother. 2015;11(2):428-34. doi: 10.4161/21645515.2014.995059. Hum Vaccin Immunother. 2015. PMID: 25692792 Free PMC article. Clinical Trial.
MF59-adjuvanted influenza vaccine (FLUAD®) elicits higher immune responses than a non-adjuvanted influenza vaccine (Fluzone®): A randomized, multicenter, Phase III pediatric trial in Mexico.
Cruz-Valdez A, Valdez-Zapata G, Patel SS, Castelli FV, Garcia MG, Jansen WT, Arora AK, Heijnen E. Cruz-Valdez A, et al. Among authors: arora ak. Hum Vaccin Immunother. 2018 Feb 1;14(2):386-395. doi: 10.1080/21645515.2017.1373227. Epub 2018 Jan 3. Hum Vaccin Immunother. 2018. PMID: 28925801 Free PMC article. Clinical Trial.
Safety and immunogenicity of a meningococcal B recombinant vaccine when administered with routine vaccines to healthy infants in Taiwan: A phase 3, open-label, randomized study.
Chiu NC, Huang LM, Willemsen A, Bhusal C, Arora AK, Reynoso Mojares Z, Toneatto D. Chiu NC, et al. Among authors: arora ak. Hum Vaccin Immunother. 2018 May 4;14(5):1075-1083. doi: 10.1080/21645515.2018.1425659. Epub 2018 Feb 15. Hum Vaccin Immunother. 2018. PMID: 29337653 Free PMC article. Clinical Trial.
Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: Results from a phase III clinical trial in children, adolescents and adults.
Kerdpanich P, Chanthavanich P, De Los Reyes MR, Lim J, Yu D, Ama MC, Mojares Z, Casula D, Arora AK, Pellegrini M. Kerdpanich P, et al. Among authors: arora ak. PLoS Negl Trop Dis. 2018 Jun 6;12(6):e0006340. doi: 10.1371/journal.pntd.0006340. eCollection 2018 Jun. PLoS Negl Trop Dis. 2018. PMID: 29874228 Free PMC article. Clinical Trial.
205 results